If the panel’s recommendations are adopted by the FDA, that would mean that Dexcom G5 users would not need to do a separate fingerstick with a meter to get a blood sugar reading for basal and bolus insulin dosing; they would, however, still need to do daily fingersticks to calibrate the device. European G5 users […]
This June, a 41-year-old man became the first European patient with Type 1 to come off insulin therapy after receiving a transplant of pancreatic islet cells using the BioHub technique. This therapy, engineered by the Diabetes Research Institute (DRI), protects transplanted islet cells from immune system attack.
At the ADA Scientific Sessions in New Orleans, Abbott shared results of the IMPACT study, a randomized six-month trial comparing the FreeStyle Libre “flash glucose monitor” to fingersticks in people with type 1 diabetes
A bloodless way to test blood sugar has long been the stuff of science fiction. But, now, a group of researchers in Wales is moving an innovative idea of drawing blood without puncturing the skin from the conceptual world of Star Trek to perhaps being available at a pharmacy down the street.
At the recent ADA Scientific Sessions, Medtronic presented data from its pivotal trial of the MiniMed 670G/Enlite 3 hybrid closed loop system, designed to provide evidence for regulatory approval.
As Medtronic prepares to seek FDA approval for an artificial pancreas, many have wondered why it’s taken so long to get to this point. A recent study suggests that might be because the FDA may be slower to approve medical devices than drugs, according to a report by Mass Device.
The Eversense CGM uses a 90-day implanted sensor that is placed in the upper arm in a 5-10 minute in-office procedure. A rechargeable transmitter device is worn on top of the skin, directly over the sensor, which powers the implant and sends the current glucose value and trend arrow to a smartphone. The transmitter is […]
Google made some big promises about how it would cure what ails us, but now it looks like we may never get those diabetes-detecting contact lenses or that FitBit-like cancer-detection wearable.
Until very recently, shots were the only way to administer insulin. But an inhalable version of this life-sustaining drug has been in the works for decades, and has recently come to market — yet its fate still hangs in the air.
Everyone with Type 1 diabetes at one time or another has had a bad low, the kind when all you want to do is eat everything in sight. There’s no reasoning with yourself – it’s as if someone has hijacked your self-control.
The long-term, “best case scenario” idea of the “perfect” smart insulin is very compelling for people with diabetes on insulin: one injection per day, blood sugar levels that stay in zone without hypoglycemia, no more carb counting, no more guessing what dose is correct, no more feeling frightened, and a much safer and less stressful […]
Top 5 tips to combat the mental stress that can accompany high blood sugars.
Locemia Solutions has been developing an intranasal glucagon that offers the possibility of eliminating glucagon injections, and the company has announced a string of positive results in key safety trials for its product in 2015. The results of the most recent study, released in December 2015, showed that its intranasal glucagon could be used effectively […]
Dexcom and Medtronic’s recent quarterly update calls shared new timing details on their latest continuous glucose monitoring (CGM) products – our team listens to all these calls and we wanted to give you a “what’s what!” update. Read below for specifics on the CGM upgrades, which will improve the experience of wearing CGM on many […]
Anyone who has had to inject glucagon during a crisis would gladly reach for something easier to use, if it were available, but only if that alternative were just as effective in staving off hypoglycemia. Locemia Solutions has been developing an intranasal glucagon that offers the possibility of eliminating glucagon injections, and the company has […]
Now researchers have come up with a simpler option – they’ve created a synthetic patch that’s covered in natural beta cells, which can be stuck painlessly to a patient’s skin to secrete insulin when it’s required and safely control blood sugar levels, no injection or monitoring required.
I had always hated math, but after weeks of constant carb counting, recording my blood glucose levels, and noting my insulin doses, I had numbers in my head all night. That made me anxious, and so did the fear of hypoglycemia. Sometimes early in the morning, my blood sugar would drop low, making me shaky […]
At the Health 2.0 Conference in early January, Bigfoot Biomedical CEO Jeffrey Brewer shared more product details and timeline information on Bigfoot’s automated insulin delivery system than ever before.
Novo Nordisk’s insulin degludec injection, known by the brand name Tresiba, met with FDA approval in late September. It is expected to be available to patients with a doctor’s prescription in the first few months of 2016, according to Novo Nordisk’s chief medical officer for North America, Dr. Todd Hobbs.
Novo Nordisk’s insulin degludec injection, known by the brand name Tresiba, met with FDA approval in late September. It is expected to be available to patients with a doctor’s prescription in the first few months of 2016, according to Novo Nordisk’s chief medical officer for North America, Dr. Todd Hobbs.